Clearpoint Neuro Inc
NASDAQ:CLPT

Watchlist Manager
Clearpoint Neuro Inc Logo
Clearpoint Neuro Inc
NASDAQ:CLPT
Watchlist
Price: 11.835 USD 6.72% Market Closed
Market Cap: 326.4m USD
Have any thoughts about
Clearpoint Neuro Inc?
Write Note

Clearpoint Neuro Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Clearpoint Neuro Inc
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Clearpoint Neuro Inc
NASDAQ:CLPT
Total Equity
$29m
CAGR 3-Years
-13%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Total Equity
$25.9B
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
18%
Boston Scientific Corp
NYSE:BSX
Total Equity
$20.7B
CAGR 3-Years
8%
CAGR 5-Years
16%
CAGR 10-Years
12%
Stryker Corp
NYSE:SYK
Total Equity
$20.1B
CAGR 3-Years
12%
CAGR 5-Years
10%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Total Equity
$39.3B
CAGR 3-Years
5%
CAGR 5-Years
4%
CAGR 10-Years
6%
Intuitive Surgical Inc
NASDAQ:ISRG
Total Equity
$15.6B
CAGR 3-Years
11%
CAGR 5-Years
15%
CAGR 10-Years
18%
No Stocks Found

Clearpoint Neuro Inc
Glance View

Market Cap
326.5m USD
Industry
Health Care

Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The company is headquartered in Solana Beach, California and currently employs 80 full-time employees. The company went IPO on 2019-07-03. The Company’s product platforms include SmartFlow Cannula and ClearPoint Navigation System Software. The SmartFlow Cannula is being utilized in approved combination product clinical and preclinical studies by pharmaceutical companies and academic research customers for various research and clinical trials in connection with delivery of therapeutic agents. The ClearPoint Navigation System Software is a software for surgical planning, navigation to target, and device delivery. The Company’s software and MRI-compatible workstation coordinate with the scanner to effectively utilize intraprocedural MR images. This provides real-time navigational instruction for the neurosurgeon to reach the desired anatomical target with a high degree of precision.

CLPT Intrinsic Value
6.784 USD
Overvaluation 43%
Intrinsic Value
Price

See Also

What is Clearpoint Neuro Inc's Total Equity?
Total Equity
29m USD

Based on the financial report for Sep 30, 2024, Clearpoint Neuro Inc's Total Equity amounts to 29m USD.

What is Clearpoint Neuro Inc's Total Equity growth rate?
Total Equity CAGR 5Y
37%

Over the last year, the Total Equity growth was 20%. The average annual Total Equity growth rates for Clearpoint Neuro Inc have been -13% over the past three years , 37% over the past five years .

Back to Top